Owens & Minor (NYSE:OMI) Price Target Increased to $28.00 by Analysts at Citigroup

Owens & Minor (NYSE:OMI) had its price target boosted by Citigroup from $24.00 to $28.00 in a report published on Tuesday morning, Benzinga reports. They currently have a neutral rating on the stock.

A number of other analysts have also weighed in on OMI. UBS Group decreased their target price on shares of Owens & Minor from $28.00 to $26.00 and set a buy rating on the stock in a report on Monday, January 29th. Barclays lifted their price objective on Owens & Minor from $21.00 to $23.00 and gave the company an equal weight rating in a research note on Wednesday, February 21st. Leerink Partnrs restated a market perform rating on shares of Owens & Minor in a research note on Monday, February 26th. StockNews.com upgraded Owens & Minor from a hold rating to a buy rating in a research report on Wednesday, February 21st. Finally, Robert W. Baird upped their price objective on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a neutral rating in a research report on Wednesday, April 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of Hold and an average target price of $23.86.

Owens & Minor Stock Down 25.7 %

Owens & Minor stock opened at $18.21 on Tuesday. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of -33.72, a P/E/G ratio of 0.76 and a beta of 0.52. The firm has a 50 day simple moving average of $25.46 and a 200 day simple moving average of $21.37. Owens & Minor has a 1-year low of $13.34 and a 1-year high of $28.35. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.03. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The company had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.67 billion. During the same period in the previous year, the business earned $0.28 earnings per share. The firm’s quarterly revenue was up 4.1% compared to the same quarter last year. On average, analysts predict that Owens & Minor will post 1.54 earnings per share for the current year.

Insider Buying and Selling at Owens & Minor

In other news, SVP Michael Wayne Lowry sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares in the company, valued at approximately $1,791,350. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, SVP Michael Wayne Lowry sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the transaction, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at $1,791,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jonathan A. Leon sold 5,000 shares of the business’s stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $24.84, for a total value of $124,200.00. Following the completion of the sale, the senior vice president now directly owns 84,673 shares of the company’s stock, valued at approximately $2,103,277.32. The disclosure for this sale can be found here. Company insiders own 3.59% of the company’s stock.

Institutional Trading of Owens & Minor

A number of institutional investors have recently made changes to their positions in the stock. Riverview Trust Co purchased a new position in shares of Owens & Minor in the first quarter worth $25,000. DekaBank Deutsche Girozentrale bought a new stake in Owens & Minor in the 3rd quarter worth $29,000. Quest Partners LLC purchased a new position in shares of Owens & Minor in the fourth quarter valued at about $41,000. Hexagon Capital Partners LLC raised its stake in shares of Owens & Minor by 1,240.2% during the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company’s stock valued at $43,000 after acquiring an additional 1,451 shares during the last quarter. Finally, GAMMA Investing LLC raised its stake in shares of Owens & Minor by 52.1% during the first quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock valued at $46,000 after acquiring an additional 563 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.